HETEROCYCLIC COMPOUNDS AND USES THEREOF

The present disclosure relates to compounds of Formula (I): (I), wherein Ring A, R1, R2, R3, and m are described herein. The present disclosure relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, labeled isotopes, or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DORICH, Stéphane, DURET, Guillaume, BEVERIDGE, Ramsay, CHAGNON, Felix, BURCH, Jason, FADER, Lee, BOILY, Marc-Olivier, ST-ONGE, Miguel
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DORICH, Stéphane
DURET, Guillaume
BEVERIDGE, Ramsay
CHAGNON, Felix
BURCH, Jason
FADER, Lee
BOILY, Marc-Olivier
ST-ONGE, Miguel
description The present disclosure relates to compounds of Formula (I): (I), wherein Ring A, R1, R2, R3, and m are described herein. The present disclosure relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, labeled isotopes, or tautomers thereof, in the treatment of cGAS-related diseases and disorders. La présente invention concerne des composés de Formule (I) : (I), dans laquelle le cycle A, R1, R2, R3 et m sont décrits dans la description. La présente invention concerne l'utilisation des composés de formule (I), et des sels, des hydrates, des solvates, des promédicaments, des stéréo-isomères, des isotopes marqués ou des tautomères de ceux-ci, dans le traitement de maladies et de troubles liés à cGAS.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023081441A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023081441A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023081441A13</originalsourceid><addsrcrecordid>eNrjZFD3cA1xDfJ3jnT28XRWcPb3DfAP9XMJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkbGBhaGJiaGjobGxKkCAH9YJMY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC COMPOUNDS AND USES THEREOF</title><source>esp@cenet</source><creator>DORICH, Stéphane ; DURET, Guillaume ; BEVERIDGE, Ramsay ; CHAGNON, Felix ; BURCH, Jason ; FADER, Lee ; BOILY, Marc-Olivier ; ST-ONGE, Miguel</creator><creatorcontrib>DORICH, Stéphane ; DURET, Guillaume ; BEVERIDGE, Ramsay ; CHAGNON, Felix ; BURCH, Jason ; FADER, Lee ; BOILY, Marc-Olivier ; ST-ONGE, Miguel</creatorcontrib><description>The present disclosure relates to compounds of Formula (I): (I), wherein Ring A, R1, R2, R3, and m are described herein. The present disclosure relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, labeled isotopes, or tautomers thereof, in the treatment of cGAS-related diseases and disorders. La présente invention concerne des composés de Formule (I) : (I), dans laquelle le cycle A, R1, R2, R3 et m sont décrits dans la description. La présente invention concerne l'utilisation des composés de formule (I), et des sels, des hydrates, des solvates, des promédicaments, des stéréo-isomères, des isotopes marqués ou des tautomères de ceux-ci, dans le traitement de maladies et de troubles liés à cGAS.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230511&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023081441A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230511&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023081441A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DORICH, Stéphane</creatorcontrib><creatorcontrib>DURET, Guillaume</creatorcontrib><creatorcontrib>BEVERIDGE, Ramsay</creatorcontrib><creatorcontrib>CHAGNON, Felix</creatorcontrib><creatorcontrib>BURCH, Jason</creatorcontrib><creatorcontrib>FADER, Lee</creatorcontrib><creatorcontrib>BOILY, Marc-Olivier</creatorcontrib><creatorcontrib>ST-ONGE, Miguel</creatorcontrib><title>HETEROCYCLIC COMPOUNDS AND USES THEREOF</title><description>The present disclosure relates to compounds of Formula (I): (I), wherein Ring A, R1, R2, R3, and m are described herein. The present disclosure relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, labeled isotopes, or tautomers thereof, in the treatment of cGAS-related diseases and disorders. La présente invention concerne des composés de Formule (I) : (I), dans laquelle le cycle A, R1, R2, R3 et m sont décrits dans la description. La présente invention concerne l'utilisation des composés de formule (I), et des sels, des hydrates, des solvates, des promédicaments, des stéréo-isomères, des isotopes marqués ou des tautomères de ceux-ci, dans le traitement de maladies et de troubles liés à cGAS.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD3cA1xDfJ3jnT28XRWcPb3DfAP9XMJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkbGBhaGJiaGjobGxKkCAH9YJMY</recordid><startdate>20230511</startdate><enddate>20230511</enddate><creator>DORICH, Stéphane</creator><creator>DURET, Guillaume</creator><creator>BEVERIDGE, Ramsay</creator><creator>CHAGNON, Felix</creator><creator>BURCH, Jason</creator><creator>FADER, Lee</creator><creator>BOILY, Marc-Olivier</creator><creator>ST-ONGE, Miguel</creator><scope>EVB</scope></search><sort><creationdate>20230511</creationdate><title>HETEROCYCLIC COMPOUNDS AND USES THEREOF</title><author>DORICH, Stéphane ; DURET, Guillaume ; BEVERIDGE, Ramsay ; CHAGNON, Felix ; BURCH, Jason ; FADER, Lee ; BOILY, Marc-Olivier ; ST-ONGE, Miguel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023081441A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DORICH, Stéphane</creatorcontrib><creatorcontrib>DURET, Guillaume</creatorcontrib><creatorcontrib>BEVERIDGE, Ramsay</creatorcontrib><creatorcontrib>CHAGNON, Felix</creatorcontrib><creatorcontrib>BURCH, Jason</creatorcontrib><creatorcontrib>FADER, Lee</creatorcontrib><creatorcontrib>BOILY, Marc-Olivier</creatorcontrib><creatorcontrib>ST-ONGE, Miguel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DORICH, Stéphane</au><au>DURET, Guillaume</au><au>BEVERIDGE, Ramsay</au><au>CHAGNON, Felix</au><au>BURCH, Jason</au><au>FADER, Lee</au><au>BOILY, Marc-Olivier</au><au>ST-ONGE, Miguel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC COMPOUNDS AND USES THEREOF</title><date>2023-05-11</date><risdate>2023</risdate><abstract>The present disclosure relates to compounds of Formula (I): (I), wherein Ring A, R1, R2, R3, and m are described herein. The present disclosure relates to the use of the compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, labeled isotopes, or tautomers thereof, in the treatment of cGAS-related diseases and disorders. La présente invention concerne des composés de Formule (I) : (I), dans laquelle le cycle A, R1, R2, R3 et m sont décrits dans la description. La présente invention concerne l'utilisation des composés de formule (I), et des sels, des hydrates, des solvates, des promédicaments, des stéréo-isomères, des isotopes marqués ou des tautomères de ceux-ci, dans le traitement de maladies et de troubles liés à cGAS.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023081441A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HETEROCYCLIC COMPOUNDS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A10%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DORICH,%20St%C3%A9phane&rft.date=2023-05-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023081441A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true